Literature DB >> 16690992

Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.

Deepika Bhargava1, Myron F Weiner, Linda S Hynan, Ramon Diaz-Arrastia, Anne M Lipton.   

Abstract

Two hundred forty-seven patients with early Alzheimer's disease were studied for the association of demographic, functional, and cognitive status and vascular comorbidities and risk factors present at index visit to rate of clinical disease progression over 3 years and to survival time. Patients who progressed to the moderate stage were designated fast progressors; those who remained in the early stage were designated slow progressors. At index visit, Mini-Mental State Exam score was significantly lower for the fast than the slow group; global impairment was significantly higher for the fast group. Cognitive scores showed greater annual decline in the fast group, and the fast group also had a greater annualized global change. The fast group had a shorter median survival time from onset, but age at onset, age at initial visit, history of heart problems, myocardial infarct, stroke, hypertension, diabetes, or past or current smoking did not differ between groups.

Entities:  

Mesh:

Year:  2006        PMID: 16690992     DOI: 10.1177/0891988706286505

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  20 in total

Review 1.  Successful aging: Advancing the science of physical independence in older adults.

Authors:  Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor
Journal:  Ageing Res Rev       Date:  2015-10-14       Impact factor: 10.895

2.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

3.  African Americans with memory loss: findings from a community clinic in Lexington, Kentucky.

Authors:  Deborah D Danner; Charles D Smith; Peace Jessa; JoAnna Hudson
Journal:  Nurs Clin North Am       Date:  2008-09       Impact factor: 1.208

4.  Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings.

Authors:  Myron F Weiner; Roger N Rosenberg; Kyle B Womack; Doris A Svetlik; Carey Fuller; Julie Fields; Linda S Hynan
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

5.  Alzheimer's disease: rapid and slow progression.

Authors:  Craig J Thalhauser; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2011-06-08       Impact factor: 4.118

Review 6.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

7.  Single neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.

Authors:  Mili Parikh; Linda S Hynan; Myron F Weiner; Laura Lacritz; Wendy Ringe; C Munro Cullum
Journal:  Clin Neuropsychol       Date:  2014-08-18       Impact factor: 3.535

8.  The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease.

Authors:  Melissa Lamar; David J Libon; Angela V Ashley; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  J Int Neuropsychol Soc       Date:  2009-10-19       Impact factor: 2.892

9.  Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

Authors:  P B Rosenberg; M M Mielke; J Tschanz; L Cook; Chris Corcoran; K M Hayden; M Norton; P V Rabins; R C Green; K A Welsh-Bohmer; J C S Breitner; R Munger; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2008-11       Impact factor: 4.105

Review 10.  The effects of tobacco smoke and nicotine on cognition and the brain.

Authors:  Gary E Swan; Christina N Lessov-Schlaggar
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.